2.95 USD
▲-0.03+5.73%
2026-08-03
市值
$24.60M
市盈率
—
EPS
-1.37
股息率
—
52 周区间
2.52 – 12.15
成交量
10.88K
Beta
0.26
目标价
11.25
52W 低 2.5252W 高 12.15
价格走势
公司简介
Evaxion A/S, a clinical-stage biotech company, develops artificial intelligence-powered immunology vaccines. The company develops EVX-01, which is in phase 2 global multi-center clinical trial for the treatment of advanced melanoma; EVX-03, DNA-based cancer vaccine for the treatment of solid tumors; and EVX-04, a therapeutic cancer vaccine candidate, which is in phase 1 trial for acute myeloid leukemia. Its programs also include vaccines that are in pre-clinical stage, which includes EVX-B1, a multi-component prophylactic vaccine targeting skin...